Trending
Shilpa Medicare gets nod for Phase III clinical trials of Human Albumin
Shilpa Medicare has informed that the Subject Expert Committee (Haematology) (SEC) has accepted the results of its Phase I clinical trials for Recombinant Human Albumin (rHA) 20% and granted approval to proceed with Phase III clinical trials.